Peringatan Keamanan

Studies in animals and humans have reported cases of serious muscle paralysis, which can lead to respiratory distress and death.

Tetraethylammonium

DB08837

small molecule experimental investigational

Deskripsi

Tetraethylammonium is an experimental drug with no approved indication or marketed formulation. The only marketed drug containing tetraethylammonium was a combination drug called Fosglutamina B6, but this drug has now been discontinued. As an experimental agent, tetraethylammonium is used in its salt forms such as tetraethylammonium chloride and tetraethylammonium bromide. Its mechanism of action is still being investigated, but it is known that tetraethylammonium blocks autonomic ganglia, calcium- and voltage- activated potassium channels, and nicotinic acetylcholine receptors. Because of its inhibitory actions at the autonomic ganglia, tetraethylammonium was thought to be a potential therapeutic vasodilator but serious toxic effects were found. The most common use of tetraethylammonium presently is as a pharmacological research agent that blocks selective potassium channels. Structurally, tetraethylammonium is positively charged due to its central quaternary ammonium.

Struktur Molekul 2D

Berat 130.2511
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Tetraethylammonium is eliminated by active renal tubular secretion by the cation transport system.

Interaksi Obat

5 Data
Risdiplam The serum concentration of Tetraethylammonium can be increased when it is combined with Risdiplam.
Vasopressin Tetraethylammonium may increase the hypertensive activities of Vasopressin.
Bethanechol The risk or severity of hypotension can be increased when Tetraethylammonium is combined with Bethanechol.
Fedratinib Fedratinib may decrease the excretion rate of Tetraethylammonium which could result in a higher serum level.
Arimoclomol The serum concentration of Tetraethylammonium can be increased when it is combined with Arimoclomol.

Target Protein

Potassium voltage-gated channel subfamily KQT member 3 KCNQ3
Potassium channel subfamily T member 2 KCNT2
Potassium channel subfamily T member 1 KCNT1
Calcium-activated potassium channel subunit beta-4 KCNMB4
Potassium voltage-gated channel subfamily A member 5 KCNA5
Aquaporin-1 AQP1
Small conductance calcium-activated potassium channel protein 2 KCNN2
Small conductance calcium-activated potassium channel protein 3 KCNN3
Multidrug and toxin extrusion protein 1 SLC47A1
Potassium voltage-gated channel subfamily A member 3 KCNA3
Small conductance calcium-activated potassium channel protein 1 KCNN1
pH-gated potassium channel KcsA kcsA
Neuronal acetylcholine receptor subunit alpha-9 CHRNA9
Calcium-activated potassium channel subunit alpha-1 Kcnma1
Potassium voltage-gated channel subfamily A member 1 KCNA1

Referensi & Sumber

Artikel (PubMed)
  • PMID: 15434379
    GRAHAM AJ: Toxic effects in animals and man after tetraethylammonium bromide. Br Med J. 1950 Aug 5;2(4674):321-2.
Textbook
  • ISBN: 978-1849736701
    O'Neil, Maryadele J. (2013). The Merck Index : An Encyclopedia of Chemicals, Drugs, and Biologicals (15th ed.). Royal Society of Chemistry, The.
  • ISBN: 978-0857110626
    Allen, Loyd V., Jr. (2012). Remington : The Science and Practice of Pharmacy (22nd ed.). Pharmaceutical Press.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul